about
Glycotherapy: new advances inspire a reemergence of glycans in medicineDerivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures.Defined Essential 8™ Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture SystemsMagnetic manipulation and spatial patterning of multi-cellular stem cell aggregatesAdult Stem Cell Therapy for Stroke: Challenges and ProgressEngineering Stem Cell OrganoidsInduction of ciliated cells from avian embryonic stem cells using three-dimensional matrix.Label-free electrophysiological cytometry for stem cell-derived cardiomyocyte clusters.Robust pluripotent stem cell expansion and cardiomyocyte differentiation via geometric patterning.Scalable stirred-suspension bioreactor culture of human pluripotent stem cells.Engineering the haemogenic niche mitigates endogenous inhibitory signals and controls pluripotent stem cell-derived blood emergence.Development of a multiplexed microfluidic platform for the automated cultivation of embryonic stem cellsAlginate encapsulation parameters influence the differentiation of microencapsulated embryonic stem cell aggregates.Immunotherapy of human cancers using gene modified T lymphocytes.Manufacturing and banking of mesenchymal stem cells.Engineering efficient retinal pigment epithelium differentiation from human pluripotent stem cells.Quantitative assessment of barriers to the clinical development and adoption of cellular therapies: A pilot studyMicrofabricated modular scale-down device for regenerative medicine process development.Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challengesEnhancing Cell therapies from the Outside In: Cell Surface Engineering Using Synthetic Nanomaterials.Model-based cell number quantification using online single-oxygen sensor data for tissue engineering perfusion bioreactors.Bioprocess forces and their impact on cell behavior: implications for bone regeneration therapy.Compartmental hollow fiber capillary membrane-based bioreactor technology for in vitro studies on red blood cell lineage direction of hematopoietic stem cells.Systematic analysis of embryonic stem cell differentiation in hydrodynamic environments with controlled embryoid body sizeHypoxia-mediated efficient expansion of human tendon-derived stem cells in vitro.Microfabricated biomaterials for engineering 3D tissues.Development of an optical system for the non-invasive tracking of stem cell growth on microcarriers.Robust, microfabricated culture devices with improved control over the soluble microenvironment for the culture of embryonic stem cellsTransplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair.Examination of the regulatory frameworks applicable to biologic drugs (including stem cells and their progeny) in Europe, the U.S., and Australia: part I--a method of manual documentary analysis.Concise review: cell therapies: the route to widespread adoption.Distinct Metabolic States Can Support Self-Renewal and Lipogenesis in Human Pluripotent Stem Cells under Different Culture ConditionsHigh-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell researchConcise review: Adipose-derived stromal vascular fraction cells and stem cells: let's not get lost in translation.Stem cell culture engineering - process scale up and beyond.Current understanding and challenges in bioprocessing of stem cell-based therapies for regenerative medicine.Embryonic stem cells for severe heart failure: why and how?Progress and prospects for stem cell engineering.Translational research and therapeutic applications of stem cell transplantation in periodontal regenerative medicine.Regenerative medicine for the treatment of heart disease.
P2860
Q27027997-F6AD156D-7272-44F7-A29A-532AFFA71836Q27313907-BA70970C-8AC4-48A8-980C-0D068F11E5D5Q27318107-D4CB4EA0-497C-4F8E-9129-210E6B1679A4Q27336464-10408459-8DE4-4925-904F-CD7A34521DF8Q28066235-36D7048A-B9F3-4BDB-B7F8-1DFBA8CDAFCFQ28973598-9FABEFF4-D826-4A74-8052-92C57F0A45A3Q30497115-82386FAC-3790-4FF9-98AA-139844064273Q30533228-6C96676B-C834-4857-9884-E1EC26304B96Q30571251-6B77A14A-29FB-4C21-A619-E4C9DD5457FEQ33617671-502F5D6E-CCCA-42EB-80C1-5F1C057E6959Q33815740-1801A56D-7649-4A41-BEA5-57A0F47D5A98Q33937577-A60DB0D3-85CB-4D0A-91EA-821497C262C6Q34178051-D6A41752-3E7D-483B-8395-4CFBAC54EA82Q34188383-A09523B0-1BF8-4672-B833-7FA80EAEAFF7Q34323739-F9CA8F8B-6772-4D80-BE42-FCD8418FC388Q34429005-D35EDEFA-E3BF-46F3-A9DC-033E3423166BQ34461176-006066B9-D333-47B5-86A2-563EF5C87A64Q34533445-385C1648-6944-4266-A4D4-6745137886E6Q35033727-ABD320D1-988E-4790-A4EC-B4B821F76960Q35142623-5747A315-6541-4298-ADEF-7EEACB5CD0A8Q35158358-F0E1923D-6B42-49E0-B6FE-EF4E7BE6AB18Q35195102-53D90903-64D5-4721-9025-7582BDA246C4Q35685767-B5FFCB7D-1DA0-463A-841D-CC5AA37F989EQ35694788-66F56193-0FB2-4B15-B09C-9D4DC45148D6Q35778570-55AA26C9-CAB3-4E34-88E5-214EE71BB1C9Q36204086-3BA133D7-15F9-4E5B-9C57-FF8528FBEEE9Q36360896-0EF8D7F3-B9FE-4C37-81E4-F3CDCCE6EA0AQ36361485-E498C8FC-3B09-4AD4-9E0D-93690E4EABE2Q36472907-2D7D8D58-89A5-415B-80A6-B565CB44BC93Q36861442-EB57812F-C08B-439E-9B09-2E51478397E6Q36861566-6EE32018-3A59-4B9C-91E1-C731C768E00DQ37168323-395E9264-70FB-447C-93CD-7303EBC9ECA4Q37461728-01F23897-F7F1-4B7D-82A0-88F5E7949559Q37857084-F0B84D26-94F8-433A-8D11-8D0F5107714CQ37896560-B6D9C010-EDD8-4392-A525-173311BCCFC7Q37919673-C4BC58C4-DBB5-4226-A6C1-A3B607A4ABA3Q37992937-1B8D56E6-EC88-44D8-9E3D-2619A2CBCA3EQ37995285-2CBFFF5D-A9C9-422B-A171-C5B91A627612Q38048961-D61D9534-8196-4E95-85B1-8EA87B10DDC0Q38075104-77B0D3FD-0E2E-4B4E-AD4F-70B6646F0641
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The systematic production of cells for cell therapies.
@ast
The systematic production of cells for cell therapies.
@en
The systematic production of cells for cell therapies.
@nl
type
label
The systematic production of cells for cell therapies.
@ast
The systematic production of cells for cell therapies.
@en
The systematic production of cells for cell therapies.
@nl
prefLabel
The systematic production of cells for cell therapies.
@ast
The systematic production of cells for cell therapies.
@en
The systematic production of cells for cell therapies.
@nl
P1433
P1476
The systematic production of cells for cell therapies.
@en
P2093
Daniel C Kirouac
Peter W Zandstra
P304
P356
10.1016/J.STEM.2008.09.001
P407
P577
2008-10-01T00:00:00Z